Anticoagulation

Anticoagulation has been studied in 26 papers since 2016: 3 trials and 10 observational studies in people, 12 reviews; 12 in the past year. The newest story, Oct 28, 2026: “Blood thinners tied to survival at 80 and up with atrial fibrillation”.

Intervention

26 papers study it14 findingsUpdated

4 new papers in 30 daysSee all 26 papers on anticoagulation

At a glance

Independent labs found the same change in people. 6 independent labs in 3 countries; 18 trials, none about aging, 4 with no results posted.

“In the time-varying Cox model, anticoagulation was associated with a 25% lower hazard of mortality (HR 0.75, 95% CI 0.71-0.79).”
Anticoagulation and All-Cause Mortality in Adults Aged 80 Years and Older with Atrial Fibrillation: A Retrospective Cohort StudyJournal of general internal medicine2026doi:10.1007/s11606-026-10920-7

None of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 6 independent labs in 3 countries
  • 18 trials, none about aging, 4 with no results posted
  • Funders: Ministerio de Economía y Competitividad and 5 more
  • Human trial3
  • Humans10

What did studies of anticoagulation find?

3

Studies of anticoagulation measured 3 outcomes: intracranial hemorrhage, Activities of Daily Living and Mini-Mental State Examination.

Intracranial hemorrhage

no changein humans1

1 study
  1. Anticoagulation was not clearly linked with intracranial hemorrhage in humans (Atrial fibrillation) (Rates 1.3-1.6% across groups).

    “ICH rates were low and comparable across groups (1.3-1.6%, p = 0.129).”

    HumansAtrial fibrillation

    Blood thinners tied to survival at 80 and up with atrial fibrillation

    Journal of general internal medicine

More on Intracranial hemorrhage

Activities of Daily Living

upin humans1

1 study
  1. Anticoagulation is linked with better Activities of Daily Living in humans (atrial fibrillation and dementia) (mean difference 10.9 points (95% CI: -19.6 to -2.3)).

    “ΔADL mean difference: 10.9 points (95% CI: -19.6 to -2.3; p = 0.02)”

    Humansatrial fibrillation and dementiamedian 28-month follow-upn = 291

    Impact of anticoagulation on cognitive decline and clinical outcomes in patients with atrial fibrillation and dementia: A retrospective cohort study

    Journal of Alzheimer's disease reports

More on Activities of Daily Living

Mini-Mental State Examination

upin humans1

1 study
  1. Anticoagulation is linked with better Mini-Mental State Examination in humans (atrial fibrillation and dementia) (mean difference 2.0 points (95% CI: -3.5 to -0.4)).

    “Anticoagulation was associated with slower cognitive/functional decline, with medium effect sizes, ΔMMSE mean difference: 2.0 points (95% CI: -3.5 to -0.4; p = 0.048)”

    Humansatrial fibrillation and dementiamedian 28-month follow-upn = 291

    Impact of anticoagulation on cognitive decline and clinical outcomes in patients with atrial fibrillation and dementia: A retrospective cohort study

    Journal of Alzheimer's disease reports

More on Mini-Mental State Examination

What is anticoagulation linked with?

10

Studies link anticoagulation with 10 measures, among them mortality, gastrointestinal bleeding and hospitalization.

Mortality

downin humans2HR 0.59–0.75

2 studies
  1. Anticoagulation is associated with mortality in humans (Atrial fibrillation) (HR 0.75, 95% CI 0.71-0.79).

    “In the time-varying Cox model, anticoagulation was associated with a 25% lower hazard of mortality (HR 0.75, 95% CI 0.71-0.79).”

    HumansAtrial fibrillationn = 45,305

    Blood thinners tied to survival at 80 and up with atrial fibrillation

    Journal of general internal medicine

  2. Anticoagulation is linked with a lower risk of mortality in humans (atrial fibrillation and dementia) (HR 0.59 (95% CI: 0.40-0.88)).

    “and all-cause mortality (HR 0.59; 95% CI: 0.40-0.88; p = 0.01).”

    Humansatrial fibrillation and dementiamedian 28-month follow-upn = 291

    Impact of anticoagulation on cognitive decline and clinical outcomes in patients with atrial fibrillation and dementia: A retrospective cohort study

    Journal of Alzheimer's disease reports

Gastrointestinal bleeding

upin humans1

1 study
  1. Anticoagulation is associated with gastrointestinal bleeding in humans (Atrial fibrillation) (Continued 13.0%, initiated 11.9%).

    “GIB was more frequent in anticoagulated patients (continued 13.0%, initiated 11.9%)”

    HumansAtrial fibrillation

    Blood thinners tied to survival at 80 and up with atrial fibrillation

    Journal of general internal medicine

More on Gastrointestinal bleeding

Hospitalization

downin humans1HR 0.6

1 study
  1. Anticoagulation is linked with a lower risk of hospitalization in humans (atrial fibrillation and dementia) (HR 0.60 (95% CI: 0.43-0.84)).

    “In multivariable Cox models, anticoagulation reduced hospitalization risk (HR 0.60; 95% CI: 0.43-0.84; p < 0.01)”

    Humansatrial fibrillation and dementiamedian 28-month follow-upn = 291

    Impact of anticoagulation on cognitive decline and clinical outcomes in patients with atrial fibrillation and dementia: A retrospective cohort study

    Journal of Alzheimer's disease reports

Poor neurological outcome at discharge

upin humans1OR 3.55

1 study
  1. Anticoagulation is linked with a higher risk of poor neurological outcome at discharge in humans (chronic SDH surgically evacuated) (OR 3.55, 95% CI 1.08-11.60).

    “anticoagulation use was found to be associated with poor outcomes (OR 3.55, 95% CI 1.08-11.60; p = 0.036).”

    Humanschronic SDH surgically evacuatedn = 130

    Extreme-aged patients (≥ 85 years) experience similar outcomes as younger geriatric patients following chronic subdural hematoma evacuation: a matched cohort study

    GeroScience

Cognitive impairment

downin humans1

1 study
  1. Anticoagulation lowers the risk of cognitive impairment in humans (patients with atrial fibrillation; through stroke risk reduction).

    “Anticoagulation has been shown to significantly reduce the risk of stroke in patients with AF and, with it, the risk of CI”

    Reviewpatients with atrial fibrillation; through stroke risk reduction

    Atrial fibrillation and cognitive impairment: a narrative review

    Revista de neurologia

More on Cognitive impairment

Stroke

downin humans1

1 study
  1. Anticoagulation lowers the risk of stroke in humans (patients with atrial fibrillation).

    “Anticoagulation has been shown to significantly reduce the risk of stroke in patients with AF”

    Reviewpatients with atrial fibrillation

    Atrial fibrillation and cognitive impairment: a narrative review

    Revista de neurologia

More on Stroke

Composite of mortality, ischemic stroke, or arterial embolism

downin humans1HR 0.38

1 study
  1. Anticoagulation is associated with composite of mortality, ischemic stroke, or arterial embolism in humans after outpatient elective electric cardioversion (Adjusted HR 0.38, 95% CI 0.27–0.52; P<0.001).

    “Postcardioversion anticoagulation was associated with lower risk of the composite end point (adjusted hazard ratio, 0.38; 95% CI, 0.27-0.52; P<0.001).”

    Humansafter outpatient elective electric cardioversion90 daysn = 7,860

    Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter

    Journal of the American Heart Association

One-month mortality

downin humans1

1 study
  1. Anticoagulation is linked with a lower risk of one-month mortality in humans (absence of anticoagulation associated with higher mortality).

    “no anticoagulation by reference for curative were independently associated with one-month mortality”

    Humansabsence of anticoagulation associated with higher mortalityone monthn = 108

    ADL-dependency, D-Dimers, LDH and absence of anticoagulation are independently associated with one-month mortality in older inpatients with Covid-19

    Aging

Intracranial bleeding

upin humans1

1 study
  1. Anticoagulation is associated with intracranial bleeding in humans after a fall.

    “anticoagulation is associated with increased risk of intracranial bleeding after a fall”

    Reviewafter a fall

    Stroke and Falls-Clash of the Two Titans in Geriatrics

    Geriatrics (Basel, Switzerland)

More on Intracranial bleeding

Hospital length of stay

upin humans1

1 study
  1. Anticoagulation is associated with hospital length of stay in humans (fall trauma; compared with patients not on anticoagulation) (6.3 ± 6.2 vs 4.9 ± 5.2).

    “Compared with patients not on anticoagulation, there was a higher LOS among patients on anticoagulation (6.3 ± 6.2 vs 4.9 ± 5.2, P = .001).”

    Humansfall trauma; compared with patients not on anticoagulationn = 1,121

    The effect anticoagulation status on geriatric fall trauma patients

    American journal of surgery

Has anticoagulation been tested in people?

0 of 18 about aging

Yes: 3 trials and 10 observational studies in people have been published, and 18 trials are registered.

In trials

All 20

Trial sponsors

Funding

4 grants since 2021

Gouvernement du Canada | Canadian Institutes of Health ResearchCA$1.9MNational Institute of Neurological Disorders and Stroke$3.7MNational Institute on Aging$844K

Latest

Dec 2025: 1Jan 2026: 1Feb 2026: 1Mar 2026: 3Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 4Nov 2026: 112 papers in 12 months
Journal of General Internal Medicine

Blood thinners tied to survival at 80 and up with atrial fibrillation

One-year mortality was 8.7% among people who continued blood thinners, versus 17.7% among those who never took them, in a retrospective cohort study.One-year mortality was 8.7% among people who continued blood thinners, versus 17.7% among those who never took them, in a retrospective cohort study.

Cohort · 45,305 peopleAtrial fibrillation

See all 26 papers on anticoagulation